Get started
Author

Toshie Mashiba

Observed names: TOSHIE MASHIBA, Toshie MASHIBA
ORCID: 0000-0002-4377-4829
Observed ORCID: 0000-0002-4377-4829
OpenAlex ID: A5020528111
Present status of autoimmune hepatitis in Japan: a nationwide survey
2011 · The Autoimmune Hepatitis Study Group, a subgroup of the Intractable Hepato-Biliary Disease Study Group in Japan, Masanori Abe, et al. · Journal of Gastroenterology · 115
Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group
2018 · Toshie Mashiba, Kouji Joko, et al. · PLoS ONE · 59
PDF
Amino acid imbalance in patients with chronic liver diseases
2010 · Kojiro Michitaka, Atsushi Hiraoka, et al. · Hepatology Research · 55
Wilms’ tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis
2008 · Toshiki Sera, Yoichi Hiasa, et al. · European Journal of Cancer · 53
Usefulness of neutrophil‐to‐lymphocyte ratio in predicting progression and survival outcomes after atezolizumab–bevacizumab treatment for hepatocellular carcinoma
2022 · Hironori Ochi, Masayuki Kurosaki, et al. · Hepatology Research · 51
PDF
Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria
2020 · Hironori Ochi, Atsushi Hiraoka, et al. · Journal of Gastroenterology · 49
PDF
Diabetes mellitus reduces the therapeutic effectiveness of interferon‐α2b plus ribavirin therapy in patients with chronic hepatitis C
2007 · Ichiro Konishi, Norio Horiike, et al. · Hepatology Research · 29
Ulcerative Colitis Complicated with Primary Biliary Cirrhosis
2011 · Fujimasa Tada, Masanori Abe, et al. · Internal Medicine · 27
PDF
Gianotti-Crosti Syndrome Caused by Acute Hepatitis B Virus Genotype D Infection
2004 · Kojiro MICHITAKA, Norio HORIIKE, et al. · Internal Medicine · 26
PDF
Real‐world efficacy of elbasvir and grazoprevir for hepatitis C virus (genotype 1): A nationwide, multicenter study by the Japanese Red Cross Hospital Liver Study Group
2019 · Toshie Mashiba, Kouji Joko, et al. · Hepatology Research · 24
PDF
Ribavirin Regulates Hepatitis C Virus Replication Through Enhancing Interferon-Stimulated Genes and Interleukin 8
2012 · Yoshio Tokumoto, Yoichi Hiasa, et al. · The Journal of Infectious Diseases · 21
Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis
2023 · Daniel Q. Huang, Nobuharu Tamaki, et al. · Hepatology · 19
Optimal threshold of alpha-fetoprotein response in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab
2022 · Nobuharu Tamaki, Toshifumi Tada, et al. · Investigational New Drugs · 18
Identification of CTL epitopes in hepatitis C virus by a genome-wide computational scanning and a rational design of peptide vaccine
2007 · Toshie Mashiba, Keiko Udaka, et al. · Immunogenetics · 17
Treatment response to durvalumab plus tremelimumab after progression with previous immune checkpoint inhibitor in unresectable hepatocellular carcinoma
2024 · Nami Mori, Nobuharu Tamaki, et al. · Investigational New Drugs · 15
Effects of long-term entecavir treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients
2015 · Takao Watanabe, Yoshio Tokumoto, et al. · Hepatology International · 15
Neuropsychiatric dysfunction in patients with chronic hepatitis and liver cirrhosis
2008 · Kojiro Michitaka, Yoshio Tokumoto, et al. · Hepatology Research · 13
Effects of antiviral therapy for hepatitis C following treatment of hepatocellular carcinoma: survey findings of the Japanese Red Cross Liver Study Group
2015 · Kouji Joko, Tohru Goto, et al. · Hepatology Research · 12
Wilms’ tumor 1 gene modulates Fas-related death signals and anti-apoptotic functions in hepatocellular carcinoma
2012 · Kazuhiro Uesugi, Yoichi Hiasa, et al. · Journal of Gastroenterology · 12
Change in Liver Function in Durvalumab Plus Tremelimumab Treatment for Unresectable Hepatocellular Carcinoma
2024 · NOBUHARU TAMAKI, NAMI MORI, et al. · Anticancer Research · 9
Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B
2022 · Shun Kaneko, Masayuki Kurosaki, et al. · Journal of Medical Virology · 9
Pemafibrate improves liver biochemistry and GLOBE scores in patients with primary biliary cholangitis: Nationwide, multicenter study by the Japanese Red Cross Liver Study Group
2025 · Keiji Tsuji, Nobuharu Tamaki, et al. · Hepatology Research · 8
A case of alcoholic liver cirrhosis complicated with iliopsoas hematoma:difficulty in discriminating the diagnosis of progressive anemia
2004 · Atsushi HIRAOKA, Kojiro MICHITAKA, et al. · Kanzo · 7
PDF
Metastasis from Renal Cell Carcinoma to Ectopic Pancreas Diagnosed after Resection
2022 · Ryo Yano, Tomoyuki Yokota, et al. · Internal Medicine · 6
PDF
Effect of Pemafibrate on Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Nationwide Multicenter Study
2025 · Yasuyuki Komiyama, Nobuharu Tamaki, et al. · JGH Open · 4
PDF
Works count: 49
Citation count: 705
H-index: 15
I10-index: 19
Year
Topic
Type